![Greg Cerra](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Greg Cerra
Conseiller Juridique Général chez Critical Care Diagnostics, Inc.
Postes actifs de Greg Cerra
Sociétés | Poste | Début | Fin |
---|---|---|---|
Critical Care Diagnostics, Inc.
![]() Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Conseiller Juridique Général | 08/01/2016 | - |
Historique de carrière de Greg Cerra
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
General Counsel | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Critical Care Diagnostics, Inc.
![]() Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Greg Cerra
- Expérience